Pennesi E, Brivio E, Ammerlaan ACJ, Jiang Y, van der Velden VHJ, Beverloo HB, Sleight B, Locatelli F, Brethon B, Rossig C, Engstler G, Nilsson A, Bruno B, Petit A, Bielorai B, Rizzari C, Rialland F, Rubio-San-Simón A, Sirvent FJB, Diaz-de-Heredia C, Rives S, Zwaan CM. Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22<sup>+</sup> acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial. haematol [Internet]. 2024Oct.1 [cited 2024Nov.26];109(10):3157-66. Available from: https://haematologica.org/article/view/haematol.2023.284409